Towards individualised treatment in ovarian cancer
- PMID: 23369680
- DOI: 10.1016/S1470-2045(13)70006-8
Towards individualised treatment in ovarian cancer
Comment on
-
Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study.Lancet Oncol. 2013 Feb;14(2):134-40. doi: 10.1016/S1470-2045(12)70572-7. Epub 2012 Dec 21. Lancet Oncol. 2013. PMID: 23261356 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
